Hostname: page-component-76c49bb84f-229nc Total loading time: 0 Render date: 2025-07-04T01:50:08.457Z Has data issue: false hasContentIssue false
  • English
  • Français

Assessment of Turkish women's knowledge concerning folic acid and prevention of birth defects

Published online by Cambridge University Press:  02 January 2007

Nurhan Unusan
Nurhan Unusan*
Affiliation:
Selcuk University, Education Faculty, Konya, Turkey
*
*Corresponding author: Email nunusan@selcuk.edu.tr
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objectives:

In Turkey, the incidence of neural tube defects (NTDs) is 30.1 per 10 000 births. For this reason it seems an important problem for women of childbearing age. Adequate periconceptional consumption of folic acid could prevent NTDs. Most women are unaware of this recommendation. The objectives of this study were to evaluate women' knowledge and beliefs with regard to folic acid, and to estimate the consumption frequency of vitamin supplements periconceptionally and during the first trimester of pregnancy.

Design:

Eight hundred and eighteen married women who had delivered a live-born infant within the previous 12 months completed the questionnaire. Each subject participated in a 20-minute interview, with the questionnaire comprising multiple-choice statements. A random sample of 10 public health centres was drawn from 27 in three districts in Konya where about 50% of the population lives.

Results:

Only 22% of subjects had heard or read about folic acid. Thirteen per cent of women indicated knowledge of the direct link between folic acid supplementation and NTD prevention. The knowledge was greatest among 26- to 35-year-olds. Women with a university degree were more likely to have heard about folic acid than were less-educated women.

Conclusion:

The results indicate that further government efforts are needed to inform the population and promote the optimal use of folic acid supplements and folate-enriched foods. It is the responsibility of national authorities to increase health education concerning folic acid and the prevention of NTDs in their countries.

Keywords

Folic acidKnowledgeNeural tube defects

Information

Type
Research Article
Information
Public Health Nutrition , Volume 7 , Issue 7 , October 2004 , pp. 851 - 855
Copyright
Copyright © The Authors 2004

References

1Butterworth, CE, Bendich, A. Folic acid and the prevention of birth defects. Annual Review of Nutrition 1996; 16: 73–97.CrossRefGoogle ScholarPubMed
2Tunçbilek, E, Boduroğlu, K, Alikaşifoğlu, M. Neural tube defects in Turkey: prevalence, distribution and risk factors. Turkish Journal of Pediatrics 1999; 41: 299–305.Google ScholarPubMed
3Committee on Genetics. Folic acid for the prevention of neural tube defects. Pediatrics 1999; 104(2): 325–7.CrossRefGoogle Scholar
4EUROCAT Working Group. 15 Years of Surveillance of Congenital Abnormalities in Europe 1980–1994. Report No. 7. Brussels: Scientific Institute of Public Health–Louis Pasteur, 1997; 50–79.Google Scholar
5Cornel, MC, Erickson, JD. Comparison of national policies on periconceptional use of folic acid to prevent spina bifida and anencephaly. Teratology 1997; 55: 134–7.3.0.CO;2-3>CrossRefGoogle ScholarPubMed
6Bailey, LB. New standard for dietary folate intake in pregnant women. American Journal of Clinical Nutrition 2000; 71(Suppl.): 1304S–7S.CrossRefGoogle ScholarPubMed
7Winship, KA, Cahal, DA, Weber, JCP, Griffin, JP. Maternal drug histories and central nervous system anomalies. Archives of Disease in Childhood 1984; 59: 1052–60.CrossRefGoogle ScholarPubMed
8Mulinaire, J, Cordero, JF, Erickson, JD, Berry, RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. Journal of the American Medical Association 1988; 260: 3141–5.CrossRefGoogle Scholar
9Bower, C, Stanley, FJ. Dietary folate as a risk factor for neural-tube-defects: evidence from a case control study in western Australia. Medical Journal of Australia 1989; 150(11): 613–9.CrossRefGoogle ScholarPubMed
10MRC Vitamin Study Research Group, Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991 338: 131–7.CrossRefGoogle Scholar
11Centers for Disease Control, Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Morbidity and Mortality Weekly Report 1992; 41: 1–7.Google Scholar
12Werler, MM, Shapiro, S, Mitchell, AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. Journal of the American Medical Association 1993; 269: 1257–61.CrossRefGoogle ScholarPubMed
13Czeizel, AE, Dudas, I, Metneki, J. Pregnancy outcomes in a randomised control trial of periconceptional multivitamin supplementation. Archives of Gynecology and Obstetrics 1994; 255(3): 131–9.CrossRefGoogle Scholar
14Bendich, A. Folic acid and prevention of neural tube defects: critical assessment of FDA proposals to increase folic acid intakes. Journal of Nutrition Education 1994; 26: 294–9.CrossRefGoogle Scholar
15Wald, NJ, Bower, C. Folic acid and the prevention of neural tube defects. British Medical Journal 1995; 310: 1019–20.CrossRefGoogle ScholarPubMed
16Shaw, GM, Schaffer, D, Velie, EM, Morland, K, Harris, JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995; 6: 219–26.CrossRefGoogle ScholarPubMed
17Food and Agriculture Organization (FAO). Nutrition Country Profiles, Turkey. Rome: FAO, 2000.Google Scholar
18Ungan, S, Ünsalan, R, Kaynak, K. Türkiye'de gıda tüketim harcama ve kompozisyon verileri analizi. Ankara: Araştırma sempozyumu, 1998.Google Scholar
19Pekcan, G, Karaağaoğlu, N. State of nutrition in Turkey. Paper presented at Workshop on Promoting Food-based Dietary Guidelines and Nutrition Education in the Near East RegionAmman16–19 November 1998.Google Scholar
20Daly, LE, Kirke, PN, Mollay, A, Weir, DG, Scott, JM. Folate levels and neural tube defects: implications for prevention. Journal of the American Medical Association 1995; 274: 1698–702.CrossRefGoogle ScholarPubMed
21Gregory, JF. Bioavailability of folate. European Journal of Clinical Nutrition 1997; 51(Suppl.): S54–9.Google ScholarPubMed
22Pfeiffer, CM, Rogers, LM, Bailey, LB, Gregory, JF. Absorption of folate from fortified cereal-grain products and supplemental folate consumed with or without food determined by using a dual-label stable-isotope protocol. American Journal of Clinical Nutrition 1997; 66: 1368–97.CrossRefGoogle ScholarPubMed
23Brouwer, IA, Dusseldorp, M, West, CE, Meyboom, S, Thomas, CMG, Duran, M, et al. Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. Journal of Nutrition 1999; 129: 1135–9.CrossRefGoogle Scholar
24Kim, YI. Folate and cancer prevention: a new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutrition Reviews 1999; 57(10): 314–21.Google ScholarPubMed
25Centers for Disease Control. Folic acid campaign and evaluation – Soutwestern Virginia, 1997–1999. Morbidity and Mortality Weekly Report 1999; 48(40): 914–8.Google Scholar
26Kloeblen, AS. Folate knowledge, intake from fortified grain products, and periconceptional supplementation patterns of sample of low-income pregnant women according to the Health Belief Model. Journal of the American Dietetic Association 1999; 99(1): 33–9.CrossRefGoogle ScholarPubMed
27Reisch, HS, Flynn, MAT. Folic acid and the prevention of neural tube defects. Canadian Journal of Public Health 2002; 93(4): 254–8.CrossRefGoogle ScholarPubMed
28Beresford, SAA. How do we get enough folic acid to prevent some neural tube defects? American Journal of Public Health 1994; 84: 348–50.CrossRefGoogle ScholarPubMed
29Frishman, GN, Spurrell, TP, Heber, WW. Folic acid – preconception knowledge and use by infertile women. Journal of Reproductive Medicine 2001; 46(12): 1025–30.Google ScholarPubMed